We invite healthcare providers to learn more about the ONO-2808-03 study. Your participation and referrals are crucial to the potential success of this study and the advancement of research in Multiple System Atrophy (MSA).
Study Overview
The ONO-2808-03 study is designed to investigate the safety and efficacy of ONO-2808 in patients diagnosed with MSA. This study aims to gather valuable data that could help advance research in this important disease area.
ONO-2808 is an investigational drug and has not received regulatory approval for any use.
If you have a patient who potentially meets the eligibility criteria and may be interested in participating in this study, please contact us using the details below, or fill out the referral form on our website.
Thank you for your interest in the 2808-03 Multiple System Atrophy --- MSA --- study recruitment effort.
We are pleased to share that we have successfully achieved our recruitment goals and are no longer seeking additional participants at this time. We appreciate your time and interest, and we wish you all the best.